Benjamin Edwards Inc’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$733K Sell
1,384
-795
-36% -$367K 0.01% 920
2026
Q1
$1.05M Buy
2,179
+18
+0.8% +$9.22K 0.01% 747
2025
Q4
$1.21M Sell
2,161
-27
-1% -$15.3K 0.01% 644
2025
Q3
$1.12M Buy
2,188
+981
+81% +$428K 0.01% 646
2025
Q2
$379K Buy
1,207
+6
+0.5% +$1.8K ﹤0.01% 934
2025
Q1
$366K Buy
1,201
+36
+3% +$12.1K 0.01% 887
2024
Q4
$387K Buy
1,165
+23
+2% +$7.8K 0.01% 911
2024
Q3
$381K Buy
1,142
+798
+232% +$303K 0.01% 886
2024
Q2
$142K Sell
344
-29
-8% -$11.5K 0.03% 381
2024
Q1
$151K Buy
373
+15
+4% +$5.27K 0.03% 374
2023
Q4
$110K Buy
358
+110
+44% +$29.7K 0.02% 403
2023
Q3
$60K Hold
248
– – 0.01% 438
2023
Q2
$60K Buy
+248
New +$51.5K 0.01% 443

Other funds holding MEDP

Benjamin Edwards Inc's MEDP Position: Q2 2026 in Review

Benjamin Edwards Inc reduced its Medpace (MEDP) stake by 36% in Q2 2026, selling an estimated $367K and leaving 1,384 shares worth $733K. The position accounts for 0.01% of the portfolio, ranked #920.

Benjamin Edwards Inc first reported a position in MEDP in Q2 2023 and has held it in 13 quarters since. The position peaked at $1.21M in Q4 2025. 700 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Benjamin Edwards Inc held 1,384 shares of Medpace worth $733K as of Q2 2026.
  • Benjamin Edwards Inc sold 795 Medpace shares in Q2 2026, an estimated $367K.
  • Medpace made up 0.01% of Benjamin Edwards Inc's portfolio in Q2 2026, its #920 holding.
  • Benjamin Edwards Inc first reported a position in Medpace in Q2 2023 and has held it in 13 quarters since.
  • Benjamin Edwards Inc's Medpace position peaked at $1.21M in Q4 2025.
  • 700 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Benjamin Edwards Inc's 13F filing for Q2 2026, filed 24 Jul 2026.